Use of long-acting cabotegravir + rilpivirine during hemodialysis and solid organ transplantation

AIDS. 2023 Jul 15;37(9):1491-1493. doi: 10.1097/QAD.0000000000003567.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Organ Transplantation*
  • Pyridones / therapeutic use
  • Renal Dialysis
  • Rilpivirine / therapeutic use

Substances

  • cabotegravir
  • Anti-Retroviral Agents
  • Pyridones
  • Rilpivirine
  • Anti-HIV Agents